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Abstract
The GB virus-B (GBV-B) nonstructural protein 5B (NS5B) encodes an RNA-dependent RNA polymerase (RdRp) with greater than 50%
sequence similarity to the hepatitis C virus (HCV) NS5B. Recombinant GBV-B NS5B was reported to possess RdRp activity (W. Zhong
et al., 2000, J. Viral Hepat. 7, 335–342). In this study, the GBV-B RdRp was examined more thoroughly for different RNA synthesis
activities, including primer-extension, de novo initiation, template switch, terminal nucleotide addition, and template specificity. The results
can be compared with previous characterizations of the HCV RdRp. The two RdRps share similarities in terms of metal ion and template
preference, the abilities to add nontemplated nucleotides, perform both de novo initiation and extension from a primer, and switch templates.
However, several differences in RNA synthesis between the GBV-B and HCV RdRps were observed, including (i) optimal temperatures
for activity, (ii) ranges of Mn2 concentration tolerated for activity, and (iii) cation requirements for de novo RNA synthesis and terminal
transferase activity. To assess whether the recombinant GBV-B RdRp may represent a relevant surrogate system for testing HCV antiviral
agents, two compounds demonstrated to be active at nanomolar concentrations against HCV NS5B were tested on the GBV RdRp. A chain
terminating nucleotide analog could prevent RNA synthesis, while a nonnucleoside HCV inhibitor was unable to affect RNA synthesis by
the GBV RdRp.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
An estimated 2–3% of the world’s human population is
chronically infected with hepatitis C virus (HCV) that
causes significant liver disease that can eventually lead to
the development of hepatocellular carcinoma (World Health
Organization, 1998; Alter and Mast, 1994). The limited
availability of and high cost associated with studies using
large nonhuman primates limits our understanding of HCV
biology and clinical management of this disease. The GB
virus-B (GBV-B) is a single-stranded positive-sense RNA
virus and is closely related to HCV, another member in the
family Flaviviridae. GBV-B is proposed to provide a small
animal model for hepatitis in Saguinus species (tamarins)
(Muerhoff et al., 1995; Simons et al., 1995), although it is
not clear whether GBV can be a substitute system for
studies of HCV replication.
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GBV-B was isolated from tamarins inoculated with a
blood sample from a surgeon (G.B.) suffering from acute
hepatitis (Deinhardt et al., 1967). GBV-B causes acute,
self-limited hepatitis in tamarins, evidenced by a rise in
serum alanine transaminase level (Schaluder et al., 1995a,
b). Although the acute nature of GBV-B infection in tama-
rins distinguishes this hepatitis from HCV infection in hu-
mans, the polyproteins from both viruses share approxi-
mately 25 to 30% similarity at the amino acid level
(Muerhoff et al., 1995), and studies using chimeric HCV
and GBV-B NS3 proteins have demonstrated functional
similarities (Butkiewicz et al., 2000). Moreover, the coding
region for GBV-B nonstructural protein 5B (NS5B) and the
HCV NS5B have 37% identity and 52% similarity of amino
acids residues (Muerhoff et al., 1995). The GBV-B NS5B
protein was recently purified and shown to possess RNA-
dependent RNA polymerase (RdRp) activity (Zhong et al.,
2000b), a function previously confirmed for HCV and
BVDV NS5Bs (Behrens et al., 1996; Zhong et al., 1998).
These studies stimulated speculation that GBV-B NS5B
may provide a useful target to test inhibitors of the HCV
RdRp. It is therefore useful to characterize the activities of
the GBV-B RdRp.
Recombinant NS5B proteins from several members of
the Flaviviridae have been demonstrated to possess a num-
ber of activities. These include the ability to (1) add non-
templated nucleotide(s) to the 3 hydroxyl of a template
(Behrens et al., 1996; Ranjith-Kumar et al., 2001); (2)
extend from a template primed with an oligonucleotide
(Behrens et al., 1996; De Francesco et al., 1996; Lohmann
et al., 1997, 1998); (3) initiate RNA synthesis using a
single-nucleotide as the primer, also known as de novo
initiation (Kao et al., 1999, 2000; Luo et al., 2000; Oh et al.,
2000; Shim et al., 2002); (4) synthesize a product using two
or more noncovalently linked templates in a mechanism
called template switching (Kim and Kao, 2001); (5) prefer-
entially use Mn2 for efficient de novo initiation and Mg2
for primer-extension (Ranjith-Kumar et al., 2002b). In this
work, we examined the biochemical activities of the GBV-B




The carboxy-terminal 23 amino acids of the GBV-B
polymerase were removed and replaced with six histidines
to facilitate solubility and protein purification. Purification
with nickel column chromatography resulted in an eluate of
90% purity which was subsequently purified using
poly(U) resin. The resulting preparation contained only the
protein of the expected size with approximate purity of
97% (Fig. 1A). Mass spectroscopy revealed that the pu-
rified protein was within 1 Da of the mass for the GBV-B
protein if the N-terminal methionine was removed, a com-
mon processing event for recombinant proteins expressed in
Escherichia coli. The protein also reacted with a polyclonal
serum generated from a peptide made from the GBV-B
RdRp sequence (Fig. 1A, lane W). These results demon-
strate that the GBV-B NS5B protein is of a quality suitable
for biochemical analysis.
To assess how the secondary structure of the GBV RdRp
compares to the HCV RdRp, CD spectroscopy was per-
formed. The CD spectra of both the GBV-B (23) and the
HCV (21) RdRps showed that both were predominantly
-helical in secondary structures. Furthermore, both have
similar melting points, with the GBV-B and HCV RdRp
losing half of their secondary structure at 48.1 and 47.8°C,
respectively (Fig. 1B). Given the degree of conservation in
the two proteins, the similarities in the spectral and thermo-
dynamic properties of the two proteins were to be expected.
Fig. 1. Expression, purification, and CD spectral analysis of the GBV-B
NS5B. (A) A 10% SDS–PAGE stained with Coomassie blue. Lane 1,
molecular weight marker whose sizes in kilodaltons (kDa) are indicated to
the left of the image of the gel. The lane labeled Ni is from the peak
fraction of a Talon affinity column. The three lanes labeled poly(U) contain
three fractions from a poly(U) column that were pooled for the RNA
synthesis assays. W identifies a lane from a Western blot using antisera to
a peptide synthesized from the GBV-B sequence to probe the proteins
eluted from a Talon column. (B) Thermal denaturation study of the GBV-B
and HCV RdRps. The HCV and GBV-B RdRps were at 2.4 and 3.1 M,
respectively. The proteins were in a buffer consisting of 20 mM Tris, 25
mM KCl, 3.2 mM DTT, 7.5 mM MgCl2, 0.37 mM NaCl, 1% glycerol pH
7.5. Data were fitted to an equation for a two-state unfolding model. Tm
values for GBV-B and HCV were 47.75  0.07 and 48.06  0.07°C,
respectively. The CD signal at 220 nM was determined from 20 to 75°C.
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Primer extension by the GBV-B RdRp
Primer-extension activity of the GBV-B RdRp was as-
sayed by monitoring the incorporation of [33P]-rGTP into an
oligo(rG13) primed poly(rC) RNA. Using this assay, we
examined how reaction conditions affect nucleotide poly-
merization. Since polymerases are metal-dependent en-
zymes, and the activities of the HCV RdRp are affected by
divalent metal (Ranjith-Kumar et al., 2002a,b), we assessed
whether different concentrations of the divalent metals
Mg2 or Mn2 could be used for template-dependent GTP
incorporation. The GBV RdRp was purified in a buffer that
lacked divalent metal. In the absence of poly(C) or exog-
enously provided divalent metal, no radiolabel incorpora-
tion was observed (Fig. 2A). However, addition of either
Mg2 or Mn2 increased RNA synthesis. Both the HCV
and the GBV RdRps exhibited high activities over a broad
range of Mg2, with the peaks being at 3 and 7.5 mM,
respectively. In the presence of a range of Mn2 from 1 to
7.5 mM, the GBV-B RdRp exhibited activity, with higher
concentrations becoming inhibitory (Fig. 2A). However,
consistent with previous studies (Lohmann et al., 1998),
1.0 mM MnCl2 was the optimal for the HCV NS5B; RNA
synthesis was reduced by 90% when greater than 3 mM
MnCl2 was added to the reaction. Contrary to the results of
Zhong et al., (2000b), we found that Mn2 is not specifi-
cally required for RNA synthesis by the GBV-B RdRp since
reactions with Mg2 as the only divalent metal were capa-
ble of efficient RNA synthesis. In addition, RNA synthesis
was consistently higher in reactions with Mg2 than with
Mn2.
Given that Mg2 is likely to be the most relevant metal
for RNA synthesis in a virus-infected cell, we determined
the KM for GTP incorporation using the primer-extension
assay. In the presence of 7.5 mM Mg2, the KM for GTP
was 0.42 M (Fig. 2B), similar to the previously reported
value of 0.54 M for the HCV RdRp (Lohmann et al.,
2000).
Additional requirements of the GBV-B RdRp in primer
extension were examined, including the effects of pH,
monovalent and divalent cations, and the incubation tem-
perature (Fig. 3A). For the GBV-B RdRp, RNA synthesis at
37°C was approximately half of that at 25°C (data not
shown). In contrast, the HCV RdRp was more active at
37°C than at 25°C (Fig. 3A and also Ferrari et al., 1999).
Both HCV and GBV-B polymerases had peak RNA syn-
thesis activities between pH 7.3 and 7.5 in a Tris buffer, and
both had significantly decreased RNA synthesis at KCl
concentrations higher than 50 mM (Fig. 3A).
To examine whether the concentration of the GBV-B
RdRp affects primer extension, assays were performed for
1 h using 2, 5, 10, 20, 30, 40 and 50 nM of the GBV-B
Fig. 3. Conditions for RNA synthesis by the GBV-B and HCV RdRps. (A)
Summary of the conditions optimal for primer extension from a poly(C)
template and oligonucleotide G primer under a variety of reaction condi-
tions. Titrations of the different conditions were performed using the
streptavidin flash plate assay. (B) Effects of increasing GBV RdRp con-
centration on RNA synthesis at 25°C. Reactions at each time point were
performed for 1 h using the Flashplate assay.
Fig. 2. Properties of the GBV-B RdRp characterized using a primer-
extension assay. (A) A comparison of the effects of increasing Mg2 and
Mn2 concentrations on RNA synthesis by the HCV and GBV-B RdRps.
The reactions containing 10 nM NS5B, 256 nM primer-template, 20 mM
Tris–HCl pH 7.5, 25 mM KCl, 3 mM dithiothreitol, and variable concen-
trations of divalent metal were incubated for 1 h at 25°C in the presence of
varying amounts of [-33P]GTP. (B) Determination of the KM for GTP.
Polymerase reactions performed with the same buffer conditions as in (A),
with MgCl2 at a final concentration of 7.5 mM. The reactions were
performed in a streptavidin-coated FlashPlate as described under Materials
and methods. The KM of 0.42 M was derived from the midpoint of the
assay.
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RdRp. At 25°C, a 20-fold increase in the GBV RdRp con-
centration resulted in a 23-fold increase in the specific
activities (Fig. 3B). However, the increase was nonlinear,
with the greatest increase in activity at the protein concen-
trations between 10 and 30 M (Fig. 3B). The nonlinear
increase in RNA synthesis demonstrates that higher concen-
trations of the GBV RdRp are preferred for productive RNA
synthesis, a feature consistent with the observations of HCV
RdRp (Wang et al., 2002). However, we cannot unambig-
uously conclude whether or not oligomerization of the
GBV-B is required for RNA synthesis.
De novo initiated RNA synthesis
Although the HCV and GBV-B RdRps are capable of
initiating RNA synthesis in a primer-dependent manner, a
de novo mechanism is likely to be the mode of initiation by
flaviviruses in cells (Kao et al., 2001). In a de novo initiation
assay, the template initiation nucleotide, a cytidylate, is
specifically recognized (Kim et al., 2000; Ranjith-Kumar et
al., 2002a). To determine whether the GBV RdRp can
initiate RNA synthesis by a de novo mechanism, we used an
RNA named LE19 (Fig. 4A). Monomers of LE19 exist in
dynamic equilibrium with a dimer that is formed through six
3-base pairs between two LE19 molecules. The primer-
extension product should generate a 32-nt product, as was
observed (Fig. 4A and B). A 19-nt product consistent with
de novo initiation was observed in reactions containing all
four NTPs whether the reaction contained both 4 mM Mg2
and 1 mM Mn2, or only 4 mM Mg2 (Fig. 4B, lanes 1 and
3). In reactions with only CTP, we observed a labeled 20-nt
product that is due to nontemplated nucleotide addition
(Fig. 4B, lane 2). This activity will be addressed in the
section below.
To determine whether the GBV-B RdRp is capable of de
novo initiation, we used a version of LE19 named LE19P,
wherein the 3-terminus was modified with a puromycin,
which allows de novo initiation but prevents primer exten-
sion. The 19-nt de novo initiated RNA was observed with
LE19P (Fig. 4B, lanes 5 and 7), thus proving that de novo
initiation does take place. In addition, de novo initiation
occurred whether Mn2 was present or not. In fact, 1 mM
Mn2 decreased de novo initiation by the GBV-B RdRp by
30–50%. This result contrasts with that from the HCV
RdRp, where Mn2 increased de novo RNA synthesis by
more than sevenfold (Ranjith-Kumar et al., 2002b). These
results demonstrate that the GBV RdRp is able to initiate
RNA synthesis by a de novo mechanism but with different
divalent metal requirements from the HCV RdRp.
The effect of divalent metals on de novo initiation by the
GBV-B RdRp was examined further (Fig. 5A). As expected,
reactions with Mg2 and Mn2 directed significant synthe-
sis levels of both de novo initiated and primer-extension
products of 19- and 32-nt, respectively. Of the other metals
tested, Ca2, Co2, Cu2, Ni2, and Zn2, there was no
synthesis with the latter three metals. However, the reaction
with 10 mM of Ca2 produced a low level of primer
extension, while the one with 1 mM of Co2 produced a low
level of de novo initiation (Fig. 5A). Mg2 at 10 mM final
concentration has a slight inhibitory effect on the GBV
RdRp, reducing the synthesis of the 19-nt RNA to 68% (Fig.
5C). Reactions with 10 mM Mn2 were reduced in RNA
synthesis by the GBV-B RdRp to less than 20% in compar-
ison to the reaction with 1 mM Mg2 (Fig. 5C). Last, the
effects of Mg2 and Mn2 on primer extension and de novo
initiation with LE19 are generally consistent with the results
for metal requirements during primer extension from a ri-
bo(C) template and oligo(G) primer.
To confirm the results concerning the requirements for
divalent metal, we used a second RNA that could direct only
de novo initiation with an RNA named 14-1 (Fig. 5B),
which was previously characterized to produces a 14-nt
initiated product (Kim and Kao, 2001). Unlike LE19, 14-1
can not efficiently produce a primer-extension product, but
can direct template switch (Kim and Kao, 2001). Only the
reactions with Mg2 and Mn2 were able to produce the
expected 14-nt product, with some presumed prematurely
terminated product being especially prominent in the reac-
Fig. 4. De novo initiation of RNA synthesis by the GBV-B RdRp. (A)
Schematic for the two conformations of LE19 that could lead to de novo
initiation and primer extension. The arrows indicate the directions of RNA
synthesis. (B) RNA synthesis from LE19 and LE19 modified with a 3
puromycin. The NTPs used in each reaction are indicated above the
autoradiogram. [-32P-]CTP is indicated as rC* and where the other three
NTPs were used, they are indicated as r3. If the reaction contained 1 mM
Mn2, it is denoted by a  in the Mn2 column. Positions of the 19- and
32-nt de novo initiated and primer-extended products are shown next to the
autoradiogram. The 20-nt RNA is the product due to the addition of a
terminal nucleotide to the 3-terminus of LE19.
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tion with Mn2. Relative quantification of the products
from 14-1 is in Fig. 5C.
In comparing the results from LE19 and 14-1, there was
a notable difference in the amounts of de novo initiated
products made in the reactions containing Mg2 and Mn2.
Production of the de novo initiated products from 14-1, but
not LE19, was stimulated several fold with Mn2. This
indicates that at least some of the effect of Mn2 is on
template usage by the GBV-B RdRp. To examine whether
there is a correlation between characteristics of the template
and the effects of Mn2, several templates between 15 and
50 nt were tested. All of these that contain an initiation
cytidylate as part of a single-stranded sequence, a feature
which was demonstrated to be conducive for de novo ini-
tiation (Kao et al., 2000). The reactions were performed
with 4 mM Mg2, and both 4 mM Mg2 and 1 mM Mn2.
For the HCV RdRp, having Mn2 in the reaction increased
the amount of de novo initiated products from all of these
templates (Fig. 5D, see products denoted with asterisks). In
contrast, in the reactions with GBV-B RdRp, only the 15-nt
product was increased in the presence of Mn2 (Fig. 5D,
compare lanes 10 and 11). Synthesis of the de novo initiated
products from longer templates were inhibited by Mn2,
with the degree of inhibition increasing with the length of
the template. These results provide an explanation for the
apparently discrepant results in Figs. 5A and B and suggest
that the Mn2-dependent effect on de novo initiation is
dependent on the length of the template. Additional analysis
is needed to understand the mechanism of this effect.
Terminal nucleotide addition by the GBV-B RdRp
Some faint products longer than the length expected
from the template were observed in the de novo initiation
reactions (e.g., Figs. 4B and 5B). These products could arise
by terminal nucleotide addition to the template and/or to the
nascent RNA. Consistent with this hypothesis, the 20-nt
product in a reaction containing only the radiolabeled CTP
(Fig. 4B, lanes 2 and 4) was not seen with LE19P, which
lacks a 3 hydroxyl and prevents nontemplated nucleotide
addition (Fig. 4B, lanes 6 and 8). These reactions demon-
strate that the GBV-B RdRp has terminal nucleotidyl trans-
ferase (TNTase) activity.
The HCV RdRp could preferentially incorporate either
AMP or CMP to the end of the template, depending on the
template sequence (Ranjith-Kumar et al., 2001). To exam-
Fig. 5. Conditions required for de novo initiation of RNA synthesis by the GBV-B RdRp. (A) RNA synthesis from LE19 in the presence of 1 or 10 mM of
different divalent metals. The GBV-B RdRp was prepared in the absence of any divalent metals in the buffer. The identity and final concentrations of different
divalent metals are indicated above the autoradiogram. The positions of the 19 and 32-nt de novo initiated and primer-extended products are indicated to the
left of the autoradiogram. (B) RNA synthesis from template 14-1 in the presence of 1 or 10 mM of different divalent metals. (C) Quantification of the amount
of de novo initiated or primer-extended products made by the GBV-B RdRp in the presence of Mg2 or Mn2. The percent of RNA synthesis is normalized
to the activity observed in the reaction with 1 mM Mg2, which is taken as 100%. (D) A correlation between the length of the template and the effects of
Mn2 on de novo initiated RNA synthesis by the HCV and GBV-B RdRps. The names of the templates denote their length. All of the templates share an
initiation cytidylate at the 3-terminus. The molecular weight marker is made from RNA 14-1 (lane 9, also marked at the top of the autoradiogram with M)
generates a multimer of 14-nt products that was previously characterized in Kim and Kao (2001). The asterisks identify the de novo initiated products.
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ine the requirements with the GBV-B RdRp, reactions were
performed with LE19 and either the -32P-radiolabeled
rCTP, rATP, or rUTP (Fig. 6A). Of the three nucleotides
tested, addition to the input template was highest with rATP
(Fig. 6A, lane 3), then with rCTP (lane 2), but barely
detectable with rUTP (lane 4). To confirm that the nucleo-
tides are added to the 3 end of the template, RNase T1
digestions were performed on products of TNTase and RNA
synthesis reactions to cleave the phosphodiester bond 3 of
a guanylate. Digestion of the newly synthesized RNA syn-
thesized by GBV-B should yield an 18-nt RNA. This was
observed in Fig. 6A, lane 6. Should the template LE19
become labeled by TNTase activity, the 18-nt RNA should
not be observed. Instead, the largest labeled product should
be 6-nt-long and migrate at the dye front with the unincor-
porated label. We did not observe the 18-nt RNA from the
putative TNTase activity, consistent with our conclusion
that the GBV-B RdRp has TNTase activity (Fig. 6A,
lane 8).
The identity of nucleotides added terminally by the HCV
RdRp is affected by template sequence (Ranjith-Kumar et
al., 2001). Previously, RNA LE19 and LE19 with the 3
cytidylate replaced with a guanylate have different abilities
to accept nontemplated nucleotides, indicating that the RNA
template sequence will regulate TNTase activity of the
RdRp (Ranjith-Kumar et al., 2001). We used a series of
14-nt RNAs containing changes preferentially localized at
the 5 and 3 ends to examine the effects of the TNTase
activity of the GBV-B RdRp. The amount of AMP and
CMP incorporation was determined, and the ratios are
shown in Fig. 6B. All RNAs except 14–16 incorporated
AMP more efficiently than CMP, suggesting that changes in
template sequence and/or structure affect the efficiency of
terminal nucleotide addition. Furthermore, a change of the
3C to a G in template 14–18 resulted in a two-fold im-
provement in incorporation efficiency. This data are consis-
tent with previous observations with the HCV RdRp that a
change of the 3-terminal nucleotide of RNA altered the
preference of the terminally incorporated nucleotide (Ran-
jith-Kumar et al., 2001). However, the template sequence
had different effects on the addition of the nontemplated
nucleotide in comparison to the HCV RdRp; with RNA
14-1, the HCV RdRp preferentially incorporated CMP
threefold more efficiently than AMP (Ranjith-Kumar et al.,
2001), while the GBV-B incorporated CMP at only a frac-
tion of the amount of AMP incorporated (Fig. 6B).
Template switch by the GBV-B RdRp
The BVDV and HCV RdRps can make product RNAs
that are multimers of the length of the template. This is
achieved by not terminating RNA synthesis at the end of a
template RNA. Instead, the ternary complex uses additional
template(s) to continue RNA synthesis (Kim and Kao,
2001). Template switch was previously examined with tem-
plate ()21dd, which allows de novo initiation but, due to
the chemically synthesized ()21dd possessing a 3
dideoxycytidylate as the 3-most nucleotide, neither primer
extension nor the ligation of two or more templates (Kim
and Kao, 2001). Hence, products that are dimeric or trimeric
in length can be generated only by a template switch mech-
anism (Kim and Kao, 2001). For the BVDV RdRp, the
dimeric RNA synthesized from ()21dd was 10% of the
monomer (Kim and Kao, 2001). However, the GBV RdRp
had a lower frequency of template switch, with only about
2% of the monomers, after normalizing for radiolabeled
incorporation. Another expectation of the production of
template-switch process is an increase in multimeric prod-
ucts with template concentrations. We tested for RNA syn-
thesis by GBV-B RdRp with increasing concentrations of
()21dd (Fig. 7A). RNA synthesis was observed only in the
presence of all four NTPs (data not shown). Furthermore,
both monomeric- and dimeric-length products were ob-
served when the template was present at 12.5 nM. When the
template was increased to 62.5 nM, trimer-length product
was observed. These results suggest that the GBV-B RdRp
could switch templates in vitro.
To demonstrate further that the GBV RdRp could switch
Fig. 6. Template requirements for TNTase activity. (A) Left panel, use of
different radiolabeled NTPs for terminal nucleotide addition to the 3-
terminus of LE19. Right panel, demonstration that the labeled RNAs
contain a terminally added nucleotide. Reactions untreated (U) or treated
with RNase T1 (T1) are indicated above the autoradiogram. An asterisk (*)
identifies the radiolabeled nucleotide. r3 denotes reactions performed in the
presence of nonradiolabeled GTP, ATP, and UTP. The lengths of the
reaction productions are indicated to the side of the autoradiograph. (B)
Examination of the effects of the template sequence on the terminal
addition of cytidylate or adenylate. The nucleotides changed in the tem-
plates are indicated in bold letters.
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templates, we used a series of three RNAs that were previ-
ously characterized for their frequency of template switch
by the BVDV RdRp (Fig. 7B) (Kim and Kao, 2001). Tem-
plates 14-1 and 14-2 were competent for high levels of
template switch that resulted in a ladder of RdRp products
that are multimers of 14-nt, while template 14-3 was much
less efficient in inducing template switch, due to a change in
the last two nucleotides at the 5-terminus from adenylates
to cytidylates (Fig. 7B). The pattern of template switch by
the GBV-B RdRp generally followed trends seen with the
BVDV and HCV RdRps, with multimers being observed
with 14-1 and 14-2 and less abundant amounts of putative
switch products with 14-3. Altogether, these results demon-
strate that the GBV-B RdRp will, at some frequency, not
terminate RNA synthesis at the 5-terminus of the template
and, instead, will use one or more additional templates for
the continuation of elongative RNA synthesis. However,
there are variations in the amount of dimeric RNAs made by
the three RdRps relative to the monomers, indicating an
inherent difference in the ability of each RdRp to perform a
switch.
Template specificity of the GBV-B RdRp
Viral RNA replication in the infected cell needs to spe-
cifically recognize the viral template. Specificity could be
attained in a number of ways, including the cotranslation of
the viral proteins with the template to be used for replica-
tion, or by the recognition of specificity determinants in the
viral RNA (Buck, 1996; Kao, 2002). The ability of the
GBV-B RdRp to use a range of different templates for RNA
synthesis portends that template specificity, except for the
3-most initiation pyrimidine, is not determined solely by
the recombinant RdRp. Instead, the viral replication com-
plex and/or the process of assembling the replicase deter-
mines template specificity. This is also the situation claimed
for the HCV RdRp (Kao et al., 2000; Luo et al., 2000;
Zhong et al., 2000a). However, several groups have ob-
served more specific recognition for one or more elements
in the viral RNA (Oh et al., 2000; Kashiwagi et al., 2002).
We examined whether the HCV and GBV-B RdRps have
specificity in RdRp–RNA interaction by using the template
for the initiation of one viral RNA product and determining
whether other viral RdRps will also recognize this RNA.
The 3 121 nt of the HCV minus-strand RNA, named H121
(Fig. 8A), was required for HCV RNA synthesis in vitro and
in the replicon system (Reigadas et al., 2001; Friebe et al.,
2001). H121 was produced along with an RNA named1G
that is identical except for the initiation cytidylate. The
HCV RdRp was able to recognize H121 and direct the
synthesis of a product of the expected size (Fig. 8B and data
not shown). Furthermore, efficient RNA synthesis requires a
3-initiation cytidylate, as 1G was reduced more than
fivefold for RNA synthesis in comparison to H121.
To examine the requirements for RNA synthesis from
H121 further, we tested the effects of lowering the GTP
concentration to 2 M (Fig. 8B). Higher GTP concentration
is required for de novo initiated RNA synthesis by the HCV
RdRp from a number of templates (e.g., Luo et al., 2000;
Kao et al., 2000; Zhong et al., 2000a; Ranjith-Kumar et al.,
2002a). Decreasing the GTP concentration to 2 M reduced
RNA synthesis to background levels, demonstrating a spe-
cial requirement for GTP, likely as the initiation nucleotide.
These reactions were performed at 0.25 M final concen-
tration of ATP, indicating that a lower concentration of ATP
is acceptable for RNA synthesis from H121. The BVDV
and GBV RdRps were also able to direct RNA synthesis
from H121 with the same requirements for the template
initiation cytidylate and for GTP. These results are consis-
tent with the results we had previously obtained with the
Fig. 7. Template switch by the GBV-B RdRp. (A) Demonstration that
template switch requires higher template concentrations. The sequence of
the chemically synthesized template used is shown above the autoradio-
gram. The 3-terminal cytidylate is a dideoxynucleotide, which prevents
primer extension and the ligation of two or more templates. The arrows
beside the autoradiogram indicate the positions of the dimeric and trimeric
products synthesized by the GBV-B RdRp. (B) Characterization of
template switch by three viral RdRps using three templates that vary in
their 5sequence. Templates 14-1, 14-2, and 14-3 were previously used
in the characterization of template switch by the BVDV RdRp and only
the nucleotides in 14-2 and 14-3 that are different from 14-1 are
shown. A portion of the autoradiogram of template switch by the
BVDV was previously published in Kim and Kao (2001). The ratio of the
dimeric to monomeric products is shown next to the sequence of the
templates.
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HCV RdRp using minimal length templates (Ranjith-Kumar
et al., 2002a,b). Furthermore, the fact that all three RdRps
are capable of RNA synthesis from an HCV template indi-
cates that the initiation site can provide specificity for RNA
synthesis in vitro by recombinant RdRps (Fig. 8).
Effects of HCV RdRp inhibitors on the GBV RdRp
Given that there are several similarities and differences in
the requirements for activities of the HCV and the GBV-B
RdRps, we wanted to determine whether drugs that can inhibit
the HCV RdRp can affect the GBV-B RdRp. Previously, a
GTP analog with a ribose-2-hydroxyl and a 3deoxy, named 3
deoxyGTP, was shown to inhibit the HCV RdRp with an IC50
and an IC90 of 85 and 750 nM, respectively. Using the primer-
extension assay, 3 deoxyGTP had an IC50 of 550 nM for the
GBV-B RdRp (Fig. 9). A benzo-1,2,4-thiadiazine compound,
compound 4 (C21H21N3O4S), was recently characterized to
inhibit RNA synthesis by the HCV RdRp in vitro with an IC50
of between 80 and 100 nM. In the cell-based replicon system,
its IC50 was approximately 500 nM (Dhanak et al., 2002).
Compound 4 was tested from 50 nM to 10 M but did not
affect the level of RNA synthesis by the GBV-B RdRp (Fig.
9). Thus, this nonnucleoside inhibitor is specific for the HCV
RdRp.
Concluding comments
The GBV-B and HCV NS5B proteins share all of the
activities determined thus far for the HCV RdRp, including
the ability to extend from a primed template, initiate de
novo (with specificity for the initiation nucleotide), generate
products from two or more noncovalently linked templates,
and add nontemplated nucleotides to the 3-terminus of
RNAs. All of the RdRps will recognize a template as long
as it contains a proper initiation site. However, a number of
details in each of the above activities are distinct for the
HCV and GBV-B RdRps, including preferences for concen-
trations of divalent metal cofactors, differences in the fre-
quency of template switch preferences, and nontemplated
nucleotide addition.
The effect of divalent metals on the GBV-B and HCV
RdRps are especially notable. The HCV RdRp strongly
prefers Mn2 for de novo initiation while Mg2 was inca-
pable of efficient de novo initiation. Mn2 and Mg2 were
capable of supporting both primer-extension and de novo
initiation by the GBV-B RdRp over a range of concentra-
tions (Figs. 2A and 5). However, reactions with Mg2
resulted in higher accumulation of both primer extension
and de novo initiation products made by the GBV-B RdRp
relative to Mn2. An unexpected feature of the effect of
Mn2 is that its effect is only observed with templates that
are shorter than 15 nt, indicating that the effect of Mn2 is
at least partially to interact with the template RNA. This
observation makes it unlikely that Mn2 will stimulate
RNA synthesis by GBV RdRp in the infected cell. Previ-
Fig. 9. Effects of two inhibitors of HCV RdRp on the GBV-B RdRp. The
concentration of the compounds used is indicated on the horizontal axis in
M. The incorporation of radiolabeled CMP is shown on the vertical axis.
3dGTP is an analog where the ribose 3 is a deoxy, while the ribose 2
contains a hydroxyl group. Compound 4 was characterized by Dhanak et
al. (2002).
Fig. 8. Template specificity for RNA synthesis by recombinant RdRps. (A)
Sequence and predicted secondary structure for the 3-terminal 121 nucle-
otides of the HCV genome, named H121, as described by Schuster et al.
(2003). The bent arrow denotes the initiation cytidylate. (B) RNA synthesis
by the HCV, BVDV, and GBV RdRps using H121 or a version of H121
named 1G where the 3-terminal initiation cytidylate is mutated to a
guanylate. The percent synthesis is calculated from the autoradiogram
shown, but is consistent in independently performed experiments.
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ously, Zhong et al. (2000b) reported that the GBV-B RdRp
specifically requires Mn2 and cannot use Mg2 for RNA
synthesis. Our results differ substantively from those of
Zhong et al. (2000b). However, our results are consistent for
a number of templates.
GBV-B infection of tamarins has been claimed to repre-
sent a potential surrogate model system to study HCV
replication. In our studies, a compound that inhibits the
HCV RdRp had no effect on the GBV-B RdRp. Together
with the differences in the various activities we tested, it is
more likely that small changes in one or a few amino acids
in the NS5B can alter the specificity for substrates required
for nucleotide polymerization and for targets for antivirals
active against HCV. Nonetheless, the GBV-B RdRp could
be useful as a system to demonstrate the specificity of a
compound for evaluating RdRp inhibitors for HCV.
Materials and methods
Cloning, expression, and purification of GBV-B NS5B
Infectious cDNA for GBV-B was kindly provided by
Drs. Jens Bukh and Robert Purcell at the National Institute
of Allergy and Infectious Diseases at the National Institutes
of Health. Primers were designed according to the published
GBV-B sequence (Bukh et al., 1999). Additional sequences
to encode an amino-terminal methionine and six carboxy-
terminal histidines were engineered to facilitate cloning into
pET-21b (Novagen). Production of soluble NS5B was in-
duced by propagating recombinant E. coli in 1 mM isopro-
pyl-thio--D-galactopyranoside (IPTG) at 25°C for 4 h.
NaCl at 300 mM and glycerol at 10% helped to maintain the
solubility of the recombinant protein. Soluble lysates were
passed onto a Talon column (Clontech Inc., Palo Alto, CA);
the column was extensively washed in buffer containing
300 mM NaCl and eluted with a gradient of imidazole up to
0.5 M. The peak of protein was dialyzed in a Tris buffer
containing 0.15 M NaCl and purified over a poly(U)-aga-
rose column (Pharmacia Inc.) and eluted with a gradient of
increasing NaCl. To quantify NS5B, serially diluted sam-
pled were electrophoresed on SDS–PAGE and scanned by
densitometry relative to BSA standards. Proteins were then
concentrated to approximately 1 mg/ml and stored in ali-
quots at 80°C.
RdRp assay
A primer-extension assay used a poly(rC):oligo(rG)-
primed substrate with the following modifications. After the
reaction was completed, 25 l of stop buffer (containing 1
Dulbecco’s phosphate-buffered saline (PBS) w/o CaCl2,
MgCl2, and 0.1 M EDTA) was added and then the reaction
mixture was transferred to Streptavidin FlashPlate (NEN
Life Science, SMP103). After incubation for 1 h capture at
room temperature, the plate was washed three times with
200 l of 1 PBS with 0.5% Tween 20. It was then vacuum
dried, and the signal was quantified by scintillation counting
(Packard Inc.).
RNA synthesis assays using virally derived RNAs were
previously described by Ranjith-Kumar et al. (2001). Stan-
dard RdRp assays consisted of 2.5 pmol of template LE21
with 50–100 ng of NS5B in 20 L. The products were
radiolabeled by the incorporation of [-32P]-CTP. Assess-
ment of whether the GBV RdRp could synthesize a nascent
RNA using more than one template (template switch) was
performed as described in Kim and Kao (2001). The tem-
plate used, dd()21, contains a 3-most dideoxynucleotide
to prevent ligation of the templates.
RNA synthesis from H121, the 3 end of the HCV 1B
genome, used [-32P]ATP (10 mCi/ml) as the radiolabel
(CTP and UTP were present at 100 M and GTP was at
200 M). RNA synthesis with H121 is less efficient with
[32P]CTP, likely due to CTP being required during the
formation of the first phosphodiester bond with H121 (Fig.
8A) (Reigadas et al., 2001). The sequence of H121 was
derived from the information in Kashiwagi et al. (2002) and
transcribed in vitro by annealing two partially overlapping
DNA oligonucleotides and extending with the Taq DNA
polymerase. The DNA oligonucleotide encoding the 5 por-
tion of H121 also contained a promoter for the T7 RNA
polymerase. Transcripts corresponding to the correct length
relative to molecular markers were excised from a 6%
denaturing gel and eluted in 0.3 M ammonium acetate
solution, checked for quantity and quality prior to use. A
mutation at the 3-terminal cytidylate was made using a
single-nucleotide change in the DNA oligonucleotide en-
coding this position.
Circular dichroism (CD) spectroscopy
CD analysis was performed on purified HCV 21 NS5B
and GBV-B 23 NS5B (0.3 mg/ml in 25 mM Tris pH 7.5,
25 mM KCl, 5 mM MgCl2, and 0.4% dimethylsulfoxide) at
20°C. Far-UV CD spectra were recorded on a Jasco J-710
CD instrument using a 0.1-cm path-length cell. Ten spectral
scans were accumulated using a time constant of 2 s with a
1 nM constant bandwidth at 50 nm/min. Thermal stability of
the GBV-B NS5B was measured by scanning the sample at
220 nm, a wavelength suitable for monitoring -helices.
The sample is heated at a rate of 1°C/min. Thermal stability
data were then analyzed using the computer program Grafit
and a fitting equation adapted from Doyle and Hensley
(1997) to predict the midpoint transition temperature (Tm).
Generation of polyclonal antisera
GBV-B NS5B synthetic peptides were selected by pro-
filing hydrophobicity/antigenicity plots using the Genetics
Computer Group sequence analysis software package
(Univ. of Wisconsin). Peptides conjugated to keyhole lim-
pet hemocyanin were provided by Multiple Peptide Systems
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(San Diego, CA) and generated to the following oligopep-
tide from GBV-B NS5B: T228PQKPTKKPPRLIS241. Poly-
clonal antibodies to this peptide were made using two rab-
bits. Sequential bleeds were tested and the serum was used
at 1:1000 dilution in Western blots.
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